Chemmedchem 2016-01-05

Discovery of 3-Hydroxy-3-phenacyloxindole Analogues of Isatin as Potential Monoamine Oxidase Inhibitors.

G Apodaca, J H McKerrow

Index: ChemMedChem 11 , 119-32, (2016)

Full Text: HTML

Abstract

A series of 3-hydroxy-3-phenacyloxindole analogues of isatin were designed, synthesized, and evaluated in vitro for their inhibitory activity toward monoamine oxidase (MAO) A and B. Most of the synthesized compounds proved to be potent and selective inhibitors of MAO-A rather than MAO-B. 1-Benzyl-3-hydroxy-3-(4'-hydroxyphenacyl)oxindole (compound 18) showed the highest MAO-A inhibitory activity (IC50 : 0.009 ± 0.001 μM, Ki : 3.69 ± 0.003 nM) and good selectivity (selectivity index: 60.44). Kinetic studies revealed that compounds 18 and 16 (1-benzyl-3-hydroxy-3-(4'-bromophenacyl)oxindole) exhibit competitive inhibition against MAO-A and MAO-B, respectively. Structure-activity relationship studies suggested that the 3-hydroxy group is an essential feature for these analogues to exhibit potent MAO-A inhibitory activity. Computational studies revealed the possible molecular interactions between the inhibitors and MAO isozymes. The computational data obtained are congruent with experimental results. Further studies on the lead inhibitors, including co-crystallization of inhibitor-MAO complexes and in vivo evaluations, are essential for their development as potential therapeutic agents for the treatment of MAO-associated neurological disorders.© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.


Related Compounds

Related Articles:

The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs.

2015-06-10

[Int. J. Neuropsychopharmacol. 17(8) , 1269-82, (2014)]

Inhibition of semicarbazide-sensitive amine oxidase attenuates myocardial ischemia-reperfusion injury in an in vivo rat model.

2011-02-14

[Leuk. Res. 88 , 302-6, (2011)]

The role of MAO-A and MAO-B in the metabolic degradation of noradrenaline in human arteries.

1998-04-01

[J. Auton. Pharmacol. 18 , 123-128, (1998)]

Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells.

2015-05-01

[J. Pharmacol. Exp. Ther. 356 , 483-92, (2016)]

Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives.

1999-11-01

[J. Pharmacol. Exp. Ther. 291 , 856, (1999)]

More Articles...